Education
About Us
Working with TipRanks
Follow Us
Genflow Biosciences Plc (GB:GENF)
LSE:GENF
Total Valuation
Genflow Biosciences Plc has a market cap or net worth of ―. The enterprise value is 7.13M.
Market Cap―
Enterprise Value7.13M
Share Statistics
Genflow Biosciences Plc has 391,047,940 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding391,047,940
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Genflow Biosciences Plc’s return on equity (ROE) is -2.24 and return on invested capital (ROIC) is -247.76%.
Return on Equity (ROE)-2.24
Return on Assets (ROA)-1.52
Return on Invested Capital (ROIC)-247.76%
Return on Capital Employed (ROCE)-2.48
Revenue Per Employee0.00
Profits Per Employee-325.74K
Employee Count5
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Genflow Biosciences Plc is -2.57. Genflow Biosciences Plc’s PEG ratio is -0.12.
PE Ratio-2.57
PS Ratio―
PB Ratio5.76
Price to Fair Value5.76
Price to FCF-2.52
Price to Operating Cash Flow-2.53
PEG Ratio-0.12
Income Statement
In the last 12 months, Genflow Biosciences Plc had revenue of 0.00 and earned -1.63M in profits. Earnings per share was -0.01.
Revenue0.00
Gross Profit-1.03K
Operating Income-1.80M
Pretax Income-1.63M
Net Income-1.63M
EBITDA-1.80M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -2.48M and capital expenditures -3.66K, giving a free cash flow of -2.49M billion.
Operating Cash Flow-2.48M
Free Cash Flow-2.49M
Free Cash Flow per Share>-0.01
Dividends & Yields
Genflow Biosciences Plc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.47
52-Week Price Change-47.50%
50-Day Moving Average1.47
200-Day Moving Average1.84
Relative Strength Index (RSI)37.94
Average Volume (3m)3.47M
Important Dates
Genflow Biosciences Plc upcoming earnings date is Sep 26, 2025, TBA Not Confirmed.
Last Earnings DateApr 23, 2025
Next Earnings DateSep 26, 2025
Ex-Dividend Date―
Financial Position
Genflow Biosciences Plc as a current ratio of 3.09, with Debt / Equity ratio of 0.00%
Current Ratio3.09
Quick Ratio3.09
Debt to Market Cap0.00
Net Debt to EBITDA0.38
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Genflow Biosciences Plc has paid -4.00 in taxes.
Income Tax-4.00
Effective Tax Rate<0.01
Enterprise Valuation
Genflow Biosciences Plc EV to EBITDA ratio is -1.95, with an EV/FCF ratio of -2.11.
EV to Sales0.00
EV to EBITDA-1.95
EV to Free Cash Flow-2.11
EV to Operating Cash Flow-2.11
Balance Sheet
Genflow Biosciences Plc has £683.97K in cash and marketable securities with £0.00 in debt, giving a net cash position of -£683.97K billion.
Cash & Marketable Securities£683.97K
Total Debt£0.00
Net Cash-£683.97K
Net Cash Per Share>-£0.01
Tangible Book Value Per Share<£0.01
Margins
Gross margin is 100.32%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin100.32%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Genflow Biosciences Plc is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―